The present study demonstrated that HCC patients with worse baseline liver function have elevated sTNFRII, ANGPTL4, and sgp130 levels, and lower sCD40L levels in the circulation at baseline and early during SBRT. The gene discussed is IL6ST; the disease is hepatocellular carcinoma.